SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10795	Companies
233305	Keywords
161901	Articles
124464	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 10/17/2025 at 13:10, 9 months 17 days ago

Sanofi's Wayrilz recommended by CHMP for IPT

Sanofi CHMP BTK Inhibitor Wayrilz Immune Thrombocytopenia
PRESS RELEASE

published on 10/17/2025 at 13:05, 9 months 17 days ago

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
CHMP recommends Sanofi's Wayrilz for EU approval to treat immune thrombocytopenia, targeting disease root cause through multi-immune modulation. Positive phase 3 study results showcased rapid platelet response and symptom improvements

Sanofi CHMP Wayrilz Immune Thrombocytopenia Multi-immune Modulation
BRIEF

published on 10/17/2025 at 13:05, 9 months 17 days ago

Sanofi faces negative EU opinion on Rezurock

Europe Sanofi CHMP Rezurock CGVHD
PRESS RELEASE

published on 10/17/2025 at 13:00, 9 months 17 days ago

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
Sanofi announces negative CHMP opinion on Rezurock for chronic graft-vs-host disease in the EU but plans to seek re-examination. Rezurock has shown efficacy in clinical studies

EU Sanofi CHMP Rezurock CGVHD
BRIEF

published on 10/08/2025 at 07:05, 9 months 26 days ago

AlphaMedixTM: Positive Phase 2 Results for the Treatment of GEP-NETs

Clinical Trial Phase 2 Innovative Therapy AlphaMedixTM TNE-GEP
BRIEF

published on 09/24/2025 at 07:10, 10 months 9 days ago

Sanofi invests $625 million to boost Sanofi Ventures

Innovation Digital Health Investment Sanofi Biotechnologies
BRIEF

published on 09/24/2025 at 07:05, 10 months 9 days ago

Sanofi Releases Q3 2025 Aide Mémoire

Investor Relations Sanofi Financial Modeling Results Announcement Q3 2025
PRESS RELEASE

published on 09/24/2025 at 07:05, 10 months 9 days ago

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Sanofi commits $625 million to Sanofi Ventures to boost biotech and digital health investments. Focus on immunology, rare diseases, neurology, vaccines

Digital Health Investment Biotech Ventures Sanofi
PRESS RELEASE

published on 09/24/2025 at 07:00, 10 months 9 days ago

Press release: Availability of the Q3 2025 Aide mémoire
Sanofi announces availability of Q3 2025 Aide mémoire for financial modeling purposes. Document covers non-comparable items, foreign currency impact, and share count

Investors Sanofi Financial Modeling Aide Mémoire Q3 2025
BRIEF

published on 09/23/2025 at 07:05, 10 months 10 days ago

Sanofi's SAR446268 Therapy Advances in the United States

Gene Therapy Sanofi SAR446268 FDA Admission Myotonic Dystrophy

Accesswire

Published on 08/01/2026 at 01:20, 2 days 13 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 13 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 13 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 2 days 14 hours ago

BioNxt Solutions Announces Option Grants
Published on 07/31/2026 at 23:20, 2 days 15 hours ago

Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.

View all ACCESSWIRE

EQS Group

Published on 08/03/2026 at 13:32, 54 minutes ago

Dr. jur. Michael Jaffé, Insolvency administrator of Electrochaea GmbH: Global patent portfolio for the production of green gas monetized - Hitachi takes over further development of the technology
Published on 08/03/2026 at 12:47, 1 hour 38 minutes ago

EQS-Adhoc: Sirma Group JSC: Transactions in Own Shares under the Share Buyback Program
Published on 08/03/2026 at 12:33, 1 hour 52 minutes ago

Diginex Announces Secured US$70 Million Funding Commitments and Extension of Long-Stop Date for Proposed Acquisition of Resulticks
Published on 08/03/2026 at 12:33, 1 hour 53 minutes ago

EQS-Adhoc: Beiersdorf Aktiengesellschaft: Beiersdorf adjusts guidance for the full year 2026 and resolves NIVEA turnaround plan for the next 18 months
Published on 08/03/2026 at 12:23, 2 hours 2 minutes ago

EQS-Adhoc: elumeo SE has entered into an agreement with a litigation funder and files a lawsuit for damages against Vodafone

Les Echos

Published on 08/03/2026 at 10:58, 3 hours 27 minutes ago

GUILLEMOT CORPORATION| Weekly report share buyback from July 27 to July 31 2026
Published on 08/03/2026 at 08:29, 5 hours 57 minutes ago

Launch of a €225 million tranche of its share buyback programme
Published on 08/03/2026 at 07:00, 7 hours 26 minutes ago

BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 07/31/2026 at 21:00, 2 days 17 hours ago

Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 18 hours ago

Share retention commitments (Dutreil Agreement)

View all LES ECHOS COMFI WIRE